Deaths from overdoses of prescription painkillers are not rising as quickly, but the reasons for that trend are unclear and could be linked to the legalization of marijuana, according to reports released today.
Deaths from overdoses of prescription painkillers are not rising as quickly, but the reasons for that trend are unclear and could be linked to the legalization of marijuana, according to reports released today.
This morning’s announcement from the Centers for Disease Control and Prevention that deaths from prescription painkillers rose just 3 percent from 2007 to 2011, after climbing 18 percent from 1999 through 2006, seemed liked good news. But analysts pointed out that as several states have approved medical marijuana laws, those that have report 25 percent fewer deaths from painkiller overdoses, according to research from Johns Hopkins’ Bloomberg School of Public Health.
Deaths from prescription painkillers have been a major public health issue for some time and a major concern to managed care organizations, which have researched how to spot potential abuse.
A study published in August 2013 by The American Journal of Managed Care outlined several key indicators that health plans could use to spot the potential for opioid abuse, which included having more than one painkiller prescription, or having overlapping prescriptions. Alarmingly, a quarter of the patients in the study had at least one indicator for abuse.
CDC’s analysis, meanwhile, links the falling death rate to declining use of methadone, well known for its use of helping heroin users kick the habit, but also prescribed as a painkiller. In 2006, the Food and Drug Administration called for more limited use of the drug.
Around the Web
CDC: Painkiller Deaths Slowing Down
Potential Misuse and Inappropriate Prescription Practices Involving Opioid Analgesics
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More